Page last updated: 2024-11-05

wb 4101 and Psychotic Disorders

wb 4101 has been researched along with Psychotic Disorders in 1 studies

N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
New, JS1
Christopher, WL1
Yevich, JP1
Butler, R1
Schlemmer, RF1
VanderMaelen, CP1
Cipollina, JA1

Other Studies

1 other study available for wb 4101 and Psychotic Disorders

ArticleYear
The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity.
    Journal of medicinal chemistry, 1989, Volume: 32, Issue:6

    Topics: Amphetamines; Animals; Avoidance Learning; Binding, Competitive; Catalepsy; Chemical Phenomena; Chem

1989